ATE132532T1 - Expression von tetanustoxinfragment c - Google Patents
Expression von tetanustoxinfragment cInfo
- Publication number
- ATE132532T1 ATE132532T1 AT90909052T AT90909052T ATE132532T1 AT E132532 T1 ATE132532 T1 AT E132532T1 AT 90909052 T AT90909052 T AT 90909052T AT 90909052 T AT90909052 T AT 90909052T AT E132532 T1 ATE132532 T1 AT E132532T1
- Authority
- AT
- Austria
- Prior art keywords
- fragment
- expression
- tetanustoxin
- tetanus toxin
- mature fragment
- Prior art date
Links
- 108010044241 tetanus toxin fragment C Proteins 0.000 title 1
- 108010055044 Tetanus Toxin Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 229940118376 tetanus toxin Drugs 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898914122A GB8914122D0 (en) | 1989-06-20 | 1989-06-20 | Polypeptide expression |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE132532T1 true ATE132532T1 (de) | 1996-01-15 |
Family
ID=10658724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90909052T ATE132532T1 (de) | 1989-06-20 | 1990-06-20 | Expression von tetanustoxinfragment c |
Country Status (9)
Country | Link |
---|---|
US (1) | US5443966A (de) |
EP (1) | EP0478602B1 (de) |
JP (1) | JP2981286B2 (de) |
AT (1) | ATE132532T1 (de) |
DE (1) | DE69024652T2 (de) |
DK (1) | DK0478602T3 (de) |
ES (1) | ES2084030T3 (de) |
GB (1) | GB8914122D0 (de) |
WO (1) | WO1990015871A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5601826A (en) * | 1989-06-30 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
GB9209118D0 (en) * | 1992-04-28 | 1992-06-10 | Sb 120 Amsterdam Bv | Vaccine compositions |
WO1994000487A1 (en) * | 1992-06-30 | 1994-01-06 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
ES2127829T3 (es) | 1992-07-31 | 1999-05-01 | Medeva Holdings Bv | Expresion de proteinas recombinantes fusionadas en bacterias atenuadas. |
GB9401787D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccine compositions |
US20030185792A1 (en) * | 1996-01-22 | 2003-10-02 | Curis, Inc. | Morphogen analogs of bone morphogenic proteins |
AU725295B2 (en) * | 1996-01-22 | 2000-10-12 | Brandeis University | Morphogen analogs and methods for producing them |
DE69731357T2 (de) * | 1996-03-23 | 2006-02-02 | The Research Foundation For Microbial Diseases Of Osaka University, Suita | Funktionelles antigenfragment von tetanustoxin und tetanusvakzine |
US5958469A (en) * | 1997-05-14 | 1999-09-28 | Eastman Kodak Company | Method for fabricating tools for molding diffractive surfaces on optical lenses |
US20100081197A1 (en) * | 1997-08-14 | 2010-04-01 | Sylvie Roux | In vivo modulation of neuronal transport |
US7923216B2 (en) | 1997-08-14 | 2011-04-12 | Institut Pasteur | In vivo modulation of neuronal transport |
ES2281135T3 (es) * | 1997-08-14 | 2007-09-16 | Institut Pasteur | Proteinas hibridas de un toxoide tetanico que migran de forma retrograda y transinaptica al snc. |
GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
PT1296715E (pt) | 2000-06-29 | 2012-01-19 | Smithkline Beecham Biolog | Composição vacinal multivalente |
EP1575505A4 (de) * | 2002-09-10 | 2007-01-24 | Vical Inc | Codon-optimierte vakzine auf polynucleotid-basis gegen infektionen mit bacillus anthracis |
DE602004017864D1 (de) * | 2003-06-23 | 2009-01-02 | Baxter Int | Trägerproteine für impfstoffe |
US20070092449A1 (en) * | 2005-04-05 | 2007-04-26 | Rafael Vazquez-Martinez | Methods for direct visualization of active synapses |
EP1790358A1 (de) * | 2005-11-23 | 2007-05-30 | Université de Reims Champagne-Ardennes | Proteinkonstrukte designed zum Targeting und Lyse von Zellen |
AU2007293673B2 (en) | 2006-09-07 | 2013-06-27 | Glaxosmithkline Biologicals S.A. | Vaccine |
EP2142211A1 (de) | 2007-05-02 | 2010-01-13 | GlaxoSmithKline Biologicals S.A. | Impfstoff |
NZ602958A (en) | 2010-03-30 | 2014-07-25 | Pfenex Inc | High level expression of recombinant toxin proteins |
WO2011143557A2 (en) | 2010-05-14 | 2011-11-17 | The Children's Hospital Of Philadelphia | Humanized ttc and methods of use thereof |
GB201105981D0 (en) | 2011-04-08 | 2011-05-18 | Glaxosmithkline Biolog Sa | Novel process |
WO2013083254A1 (en) | 2011-12-09 | 2013-06-13 | Bavarian Nordic A/S | Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
DK2863943T3 (en) | 2013-03-08 | 2016-11-07 | Janssen Vaccines & Prevention Bv | acellular pertussis vaccines |
JP2017521408A (ja) | 2014-07-02 | 2017-08-03 | スフェリウム バイオメッド エス.エル. | 無毒性破傷風毒素cフラグメント(ttc)を使用して筋量を増加させる方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2355094C3 (de) * | 1973-11-03 | 1979-05-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanus-Impfstoffs |
GB8516442D0 (en) * | 1985-06-28 | 1985-07-31 | Wellcome Found | Cloned antigen |
-
1989
- 1989-06-20 GB GB898914122A patent/GB8914122D0/en active Pending
-
1990
- 1990-06-20 WO PCT/GB1990/000943 patent/WO1990015871A1/en active IP Right Grant
- 1990-06-20 JP JP2508664A patent/JP2981286B2/ja not_active Expired - Lifetime
- 1990-06-20 DK DK90909052.4T patent/DK0478602T3/da active
- 1990-06-20 DE DE69024652T patent/DE69024652T2/de not_active Expired - Lifetime
- 1990-06-20 EP EP90909052A patent/EP0478602B1/de not_active Expired - Lifetime
- 1990-06-20 ES ES90909052T patent/ES2084030T3/es not_active Expired - Lifetime
- 1990-06-20 AT AT90909052T patent/ATE132532T1/de not_active IP Right Cessation
-
1993
- 1993-08-23 US US08/110,786 patent/US5443966A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2981286B2 (ja) | 1999-11-22 |
EP0478602A1 (de) | 1992-04-08 |
DE69024652T2 (de) | 1996-05-15 |
US5443966A (en) | 1995-08-22 |
WO1990015871A1 (en) | 1990-12-27 |
EP0478602B1 (de) | 1996-01-03 |
GB8914122D0 (en) | 1989-08-09 |
JPH04506005A (ja) | 1992-10-22 |
ES2084030T3 (es) | 1996-05-01 |
DE69024652D1 (de) | 1996-02-15 |
DK0478602T3 (da) | 1996-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69024652D1 (de) | Expression von tetanustoxinfragment c | |
DK0423302T3 (da) | Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner | |
DE69329202T2 (de) | Methoden der erhöhung der sekretion von überexpremierten proteinen | |
ATE188508T1 (de) | Impfstoffe gegen diphtherietoxin | |
DE69002817D1 (de) | Vakzine. | |
FI961886A0 (fi) | Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit | |
ES2103366T3 (es) | Hidrolizado proteico de guisante, metodo para su produccion y su utilizacion. | |
FI952148A (fi) | Geenitekninen menetelmä ja isäntä ksylitolin valmistamiseksi | |
JPS57134465A (en) | Manufacture of 1,5-didesoxy-1,5-imino-d- glucitol or n-derivative thereof | |
DE59308000D1 (de) | Immunoassay zum nachweis von kollagen oder kollagenfragmenten | |
TW362096B (en) | Novel piperidine derivatives and the process for preparing the same | |
EP0146026A3 (en) | Dna encoding rabbit tnf, vector having said dna inserted thereinto, host transformed with said vector, rabbit tnf polypeptide, and process for production thereof | |
ATE81136T1 (de) | Immunogenes produkt, erhalten durch expression in einer rekombinanten hefe, und verfahren zu seiner reinigung. | |
ES8704975A1 (es) | Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum | |
DE69328992D1 (de) | Mutanten von menschlichem Antithrombin III | |
NO913078L (no) | Oekt proteinproduksjon i dyr. | |
ES2023560A6 (es) | Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida. | |
ATE106744T1 (de) | Neue methode zur induzierung der ovulation beim menschen. | |
SE8403929L (sv) | Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas | |
ATE126794T1 (de) | Verfahren zur herstellung von formyltetrahydropyranen. | |
MC1627A1 (fr) | Procede de production d'un interferon immun | |
DK0592574T3 (da) | Fremgangsmåde til fremstilling af rekombinante proteiner og værtsceller anvendt derved | |
ES2004438A6 (es) | Un metodo para producir una proteina trombolitica | |
JPS52117611A (en) | Production of magnetic head |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |